ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2330

Mucosal-Associated Invariant T Cells Are Inactivated by IFNα and Reduced in Systemic Lupus Erythematosus

Asako Chiba1, Naoto Tamura2, Ran Matsudaira3, Takashi Yamamura1, Yoshinari Takasaki2 and Sachiko Miyake1, 1Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 3Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Mucosal-associated invariant T (MAIT) cells are a subset of innate-like lymphocytes which are restricted by the MHC-related molecule-1 (MR1) and express an invariant TCRα chain:Vα7.2-Jα33 in humans and Vα19-Jα33 in mice with a limited set of Vβ chains. Although the function of MAIT cells is not well known, like other innate-like lymphocytes, MAIT cells have been suggested to play both proinflammatory and regulatory roles in autoimmune models. We previously demonstrated that MAIT cells exerted a suppressive activity on T cells and the frequency of MAIT cells was reduced in patients with multiple sclerosis. In this study, we sought to investigate mechanisms by which MAIT cells are activated/inactivated and whether MAIT cells are relevant to other human autoimmune diseases including systemic lupus erythematosus(SLE).

Methods: Whole blood samples or peripheral blood mononuclear cells (PBMC) of SLE patients as well as healthy volunteers were stained with anti-human monoclonal antibodies(mAb) against CD3, γδTCR, invariant Vα7.2TCR, and CD161 and analyzed by FACS. MAIT cells were identified as CD3+γδTCR–Vα7.2TCR+CD161highcells. PBMC or FACS sorted MAIT cells were labeled with CellTrace Violet dye and stimulated with anti-CD3mAb and anti-CD28mAb or various types of cytokines. 6-7 days later, the cell proliferation was analyzed by FACS.

Results: As previously demonstrated, the frequency of MAIT cells of healthy controls was about 5% among T cells. The percentages of MAIT cells of SLE patients were 10-fold lower compared with those of healthy subjects. MAIT cells proliferated upon TCR stimulation when cultured with other PBMC. However, sorted MAIT cells failed to respond to anti-CD3mAb and anti-CD28mAb stimulation. MAIT cells and γδT cells were activated and proliferated by IL-15 even without exogenous TCR stimuli. MAIT cell proliferation was markedly suppressed by IFNα, but IFNα had little effect on TCR-stimulated γδT cell proliferation.

Conclusion: This study demonstrates that MAIT cell activation greatly depends on cytokines. As IFNα is known to be related to the pathogenesis of SLE, the abnormal balance of cytokines may be responsible to the reduced frequency of MAIT cells in SLE.


Disclosure:

A. Chiba,
None;

N. Tamura,
None;

R. Matsudaira,
None;

T. Yamamura,
None;

Y. Takasaki,
None;

S. Miyake,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mucosal-associated-invariant-t-cells-are-inactivated-by-ifn%ce%b1-and-reduced-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology